Abbott 3Q09 3Q Revenues: $7.8 billion (+4%) 3Q Earnings: $1.5 billion (+37%) YTD Revenues: $22.0 billion (+2%) YTD Earnings: $4.2 billion (+26%) Comments: Pharma revenues for 3Q09 were $4.1 billion, a 2% drop from last year. Currency fluctuation accounted for a 6% shortfall. Pharma sales for YTD were $11.6 billion, down 4% (with a 7% hit from currency). Pharma sales were led by Humira, which posted sales of $1.5 billion (+24%) in 3Q09 and $3.8 billion (+21%) YTD. Depakote sales pl...